Literature DB >> 3797989

Reactivity of autonomic nervous control of heart rate in diabetes mellitus and juvenile rheumatoid arthritis.

A Lindqvist, R Erkolahti, E Heinonen, I Välimäki.   

Abstract

Autonomic cardiac control of children with diabetes mellitus (DM, n = 12), juvenile rheumatoid arthritis (JRA, n = 12) and healthy controls (n = 12) was studied by a procedure consisting of a deep breathing test and an intermittent tilting test. Frequency selective entrainment of HR could be produced by tilting and deep breathing. No statistically significant intergroup differences were detected in the patterns of average heart rate (HR), overall or beat-to-beat heart rate variability (HRV) or HRV spectra. The DM group had an 8% higher HR and a limited short-term HRV response in relation to HR throughout the whole test procedure compared to controls. This increased HR causes an extra load to the cardiovascular system. We conclude that in spite of elevated HR and changed short-term chronotropic HR control in DM no features of autonomic failure could be detected in children with JRA.

Entities:  

Mesh:

Year:  1986        PMID: 3797989     DOI: 10.3109/00365518609084049

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  3 in total

1.  Combined water bath and rocking tilt table stimulator to test autonomic function by a thermal and postural entrainment method.

Authors:  A Lindqvist
Journal:  Med Biol Eng Comput       Date:  1989-07       Impact factor: 2.602

2.  Testing of heat exchanging capacity and effect of the subject's position on thermal entrainment in a water bath stimulator.

Authors:  A Lindqvist; J Jalonen; P Parviainen; L Halkola; K Antila; L A Laitinen
Journal:  Med Biol Eng Comput       Date:  1989-07       Impact factor: 2.602

3.  Heart rate variability in diabetic children: sensitivity of the time- and frequency-domain methods.

Authors:  A Akinci; A Celiker; E Baykal; T Teziç
Journal:  Pediatr Cardiol       Date:  1993-07       Impact factor: 1.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.